Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C.

Cell Metab. 2008 Dec;8(6):502-11. doi: 10.1016/j.cmet.2008.09.012. Epub 2008 Oct 30.

2.

Into the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2.

Knutson MD.

Nutr Rev. 2009 May;67(5):284-8. doi: 10.1111/j.1753-4887.2009.00200.x. Review.

PMID:
19386032
3.

Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.

Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, López-Otín C.

Haematologica. 2009 Jun;94(6):840-9. doi: 10.3324/haematol.2008.001867. Epub 2009 Apr 18. Review.

4.

Role of matriptase-2 (TMPRSS6) in iron metabolism.

Lee P.

Acta Haematol. 2009;122(2-3):87-96. doi: 10.1159/000243792. Epub 2009 Nov 10. Review.

5.

Matriptase-2, a regulatory protease of iron homeostasis: possible substrates, cleavage sites and inhibitors.

Stirnberg M, Gütschow M.

Curr Pharm Des. 2013;19(6):1052-61. Review.

PMID:
23016685
6.

Iron refractory iron deficiency anemia.

De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, Gouya L, Camaschella C, Beaumont C.

Haematologica. 2013 Jun;98(6):845-53. doi: 10.3324/haematol.2012.075515. Review.

7.

Regulation of hepcidin and iron-overload disease.

Lee PL, Beutler E.

Annu Rev Pathol. 2009;4:489-515. doi: 10.1146/annurev.pathol.4.110807.092205. Review.

PMID:
19400694
8.

Fine tuning of hepcidin expression by positive and negative regulators.

Muckenthaler MU.

Cell Metab. 2008 Jul;8(1):1-3. doi: 10.1016/j.cmet.2008.06.009. Review.

9.

The role of TMPRSS6/matriptase-2 in iron regulation and anemia.

Wang CY, Meynard D, Lin HY.

Front Pharmacol. 2014 May 19;5:114. doi: 10.3389/fphar.2014.00114. eCollection 2014. Review.

10.

Iron-refractory iron deficiency anemia: new molecular mechanisms.

Cui Y, Wu Q, Zhou Y.

Kidney Int. 2009 Dec;76(11):1137-41. doi: 10.1038/ki.2009.357. Epub 2009 Sep 23. Review.

11.

Iron-refractory iron deficiency anemia.

Finberg KE.

Semin Hematol. 2009 Oct;46(4):378-86. doi: 10.1053/j.seminhematol.2009.06.006. Review.

PMID:
19786206
12.

Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.

Cau M, Melis MA, Congiu R, Galanello R.

Expert Rev Hematol. 2010 Apr;3(2):205-16. doi: 10.1586/ehm.10.2. Review.

PMID:
21083463
13.

Iron absorption and metabolism.

Anderson GJ, Frazer DM, McLaren GD.

Curr Opin Gastroenterol. 2009 Mar;25(2):129-35. doi: 10.1097/MOG.0b013e32831ef1f7. Review.

PMID:
19528880
14.

Hemojuvelin: the hepcidin story continues.

Malyszko J.

Kidney Blood Press Res. 2009;32(2):71-6. doi: 10.1159/000208988. Epub 2009 Mar 14. Review.

15.

Current status of iron metabolism: Clinical and therapeutic implications.

Conde Diez S, de Las Cuevas Allende R, Conde García E.

Med Clin (Barc). 2017 Mar 3;148(5):218-224. doi: 10.1016/j.medcli.2016.10.047. Epub 2017 Jan 7. Review. English, Spanish.

PMID:
28073521

Supplemental Content

Support Center